John J Giordano, Pioneer In Holistic Addiction Treatment, Asked To Join JRDS Editorial Board
John J Giordano, DHL, MAC, a pioneer in holistic addiction treatment and founder/former owner of G & G Holistic Addiction Treatment Center, has accepted Dr. Kenneth Blum’s invitation to join the editorial board of The Journal of Reward Deficiency Syndrome (JRDS). Giordano’s primary responsibility as an editorial board member will be to review papers, thereby providing a consistent level of quality in the reviewing process.
The Journal of Reward Deficiency Syndrome (JRDS) is a new peer-reviewed quarterly published journal that covers the experimental, clinical and epidemiological areas of research which involves the gene associations (including environmental epigenetics) especially the genes involved in brain reward circuitry. It will provide a platform for understanding of the commonality of brain function in substance and non-substance addictive behaviors. In addition to original research, the journal features review articles, clinical studies reports, case reports, hypotheses, letters to editors, articles with novel techniques and book reviews. For more information please visit: http://blumsrewarddeficiencysyndrome.com/
Below you’ll find a list of all the Journal of Reward Deficiency Syndrome (JRDS) Editorial Board Members.
John J Giordano is a pioneer in holistic addiction treatment. He is the founder and former president of G & G Holistic Addiction Treatment Center, a 62 bed in/out patient JCAHO accredited facility located in North Miami Beach, Florida. During his tenure as president, Giordano was one of the first to introduce holistic modalities into the mainstream of addiction treatment. Decades of scientific research has borne out Giordano’s early beliefs that addiction is a mosaic of many seemingly unrelated parts – and each part requires specialized modalities.
Giordano has contributed to sixty-five papers that have been published in peer reviewed scientific and medical journals. He looks upon this new appointment as an opportunity to further the understanding and effects of Reward Deficiency Syndrome (RDS) in the medical field as well as the public domain. His fervent belief is that a through understanding of RDS is the key to effective addiction treatment and fewer relapses.
CREDENTIALS: John Giordano is the former president and co-founder of the prestigious G & G Holistic Addiction Treatment Center, a 62 bed in-patient/out-patient JACHO accredited addiction treatment center, he’d started over twenty-years ago, and The National Institute Of Holistic Addiction Studies (NIFHAS). He is the proud recipient of a Doctor Of Human Letters from Sinai University in Jerusalem. Giordano is a recovering addict with twenty-nine years of sobriety to his credit. Mr. Giordano is a therapist, Certified Addiction Professional (CAP), a Master Addictions Counselor (MAC), Certified Eye Movement Desensitization and Reprocessing (EMDR) Specialist, Trauma Relief Specialist (TRT), Certified Hypnotherapist and a Certified Criminal Justice Specialist (CCJS). Mr. Giordano also earned a Masters Certification in Neurolinguistics Programming (NLP). He is a professional expert witness for the state and federal government. John is a Karate Grand Master 10th degree black belt and is in the Karate Hall Of Fame. Mr. Giordano is the chaplain of the North Miami Police Department. For more information please visit http:/www.holisticaddictioninfo.com
CREDENTIALS: Dr Kenneth Blum made global headlines with his co-discovery of the “Reward Gene,” published by the peer-reviewed Journal of the American Medical Association (JAMA) in 1990. Dr Blum is considered by many as the father of “Psychiatric Genetics” and Neuroadaptagen Amino-Acid Therapy (NAAT). Currently, Dr. Blum is Chairman of the Board and Chief Scientific Officer of LifeGen, Inc. San Diego, California and managing partner of Reward Deficiency Solutions, LLC, and San Diego, California. He was formerly Full Professor of Pharmacology, University of Texas, at San Antonio, Texas for 23 years (retired). He is currently Full Professor of the Department of Psychiatry and McKnight Brain Institute University of Florida College of Medicine, Gainesville Florida. He served as Research Professor in the Department of Physiology and Pharmacology, Wake forest College of Medicine, Winston-Salem, North Carolina. He serves as scientific Director, PATH Foundation, New York. He has received numerous awards including NIDA Career Teacher Award; American Chemical Society Speakers Award; Gordon Conference Research Award; Presidential Excellence award (National Council of Alcoholism and Drug Abuse). Dr Blum has authored and edited eleven books, was an editor –in –chief of an Elsevier Journal, and has published over 400 peer reviewed papers. Coined “Brain Reward Cascade and Reward Deficiency Syndrome RDS) and is credited as the lead author in the first association of the Dopamine D2 receptor gene with severe alcoholism (JAMA, 1990). Dr. Blum holds both US & foreign patents on Nutrigenomics. He serves on 7 editorial boards and is the associate editor on two boards including section editor of Integrative Omics and Applied Biotechnology journal and is an ad hock reviewer for 40 journals world-wide.
Journal of Reward Deficiency Syndrome (JRDS)
Editorial Board Members
Kenneth Blum, PhD, DHL
University of Florida, USA
Editor-in-Chief
Rajendra Badgaiyan, MD
University of Minnesota, USA
Co-Editor-in-Chief
Founding Honorary Board
Eric J. Nestler, MD, PhD
Mount Sinai School of Medicine, USA
David E. Comings, MD
City of Hope National Medical Center, USA
Mark S. Gold, MD
University of Florida, USA
Eliot Gardner, PhD
National Institute on Drug Abuse, USA
David E. Smith, MD
University of California at San Francisco, USA
Marc Potenza, MD, PhD
Yale University, USA
Boris Tabakoff, PhD
University of Colorado at Denver, USA
Horace Loh, PhD
University of Minnesota, USA
Marlene Oscar-Berman, PhD
Boston University, USA
Andrew Smolen, PhD
University of Colorado at Boulder, USA
Michael Ritsner, MD
Sha’ar Menashe Mental Health Center, Israel
Philip Gorwood, MD, PhD
Paris Descartes University, France
Tomas Palomo, MD, PhD
Universidad Complutense de Madrid, Spain
Mauro Ceccanti, MD
University of Rome, Italy
Jason Connor, PhD, FAPS
The University of Queensland, Australia
Frederick Toates, DPhil, DSc
The Open University, UK
Mark Griffiths, PhD
Nottingham Trent University, UK
Associate Editorial Board
Panayotis K. Thanos, PhD
SUNY Stony Brook, USA
Marcelo Febo, PhD
University of Florida, USA
Subhash Pandey, PhD
University of Illinois at Chicago, USA
Jhodie Duncan, PhD
University of Melbourne, Australia
Kelvin Lim, MD
University of Minnesota, USA
Zsolt Demetrovics, PhD
Eötvös Loránd University, Hungary
Igor Elman, MD
Harvard Medical School, USA
Thomas Simpatico, MD
University of Vermont, USA
Brett Haberstick, PhD
University of Colorado at Boulder, USA
David Baron, DO, MSEd
USC University, USA
John Femino, MD
Meadows Edge Recovery Center, USA
M. Foster Olive, PhD
Arizona State University, USA
Edward Modestino, PhD
Boston University, USA
A. Kenison Roy, MD
Tulane University Medical School, USA
Sara Jo Nixon, PhD
University of Florida, USA
Debmalya Barh, PhD
Institute of Integrative Omics and Applied Biotechnology, India
Bryan Yamamoto, PhD
University of Toledo, USA
Subject Editors
Eric R. Braverman, MD
University of Florida, USA
Joachim Uys, PhD
Medical University of South Carolina, USA
Wayne Westcott, PhD
Quincy College, USA
Peter R. Martin, MD
Vanderbilt University School of Medicine, USA
William S. Jacobs, MD
Georgia Regents University, USA
Richard Gustin, PhD
Orexo, USA
Daniel H. Angres, MD
Northwestern Feinberg School of Medicine, USA
Pauline Gee, PhD
BodySync, USA
David Han, PhD
University of Texas at San Antonio, USA
Habibeh Khoshbouei, PhD
University of Florida, USA
Adi Jaffe, PhD
Alternatives Behavioral Health, USA
Aviv Weinstein, PhD
Hadassah Medical Organization, Israel
A. Bowirrat, PhD
The Nazareth English Hospital (EMME), Israel
Barry Tolchard, PhD
University of New England, Australia
Deborah Matteliano, PhD
State University of New York, Buffalo, USA
John J. Giordano, DMD
National Institute of Holistic Addiction Studies, USA
Ioannis N. Mavridis, MD, PhD
K.A.T.-N.R.C. General Hospital of Attica, Greece
Thomas McLaughlin, MD
Center For Psychiatric Medicine, Massachusetts, USA
Trevor Archer, PhD
University of Gothenburg, Sweden
Frederick G. Moeller, MD
Virginia Commonwealth University, USA
